|
|
 |
|
Viewing report
|
|
|
|
Par Pharmaceutical Companies, Inc. - SWOT Analysis - SWOT Analysis
Datamonitor, Oct 2008, Pages: 24
The Par Pharmaceutical Companies, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Par Pharmaceutical Companies (Par Pharmaceutical) is a holding company engaged in the production, marketing, and distribution of generic and branded pharmaceutical products. The company primarily operates in the US. The company is headquartered in Woodcliff Lake, New Jersey, and employs about 700 people. The company recorded revenues of $769.7 million during the fiscal year (FY) ended December 2007, an increase of 6.1% over 2006 primarily due to new product launches and royalties on the sales of ondansetron tablets. The operating profit of the company was $73.5 million during FY2007, as compared to an operating profit of $7.7 million in 2006. The net profit was $51.1 million in FY2007, as compared to a net profit of $6.7 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Customers who bought this item also bought
Par Pharmaceutical Companies, Inc. - Financial and Strategic Analysis Review
Par Pharmaceutical Generics Company Intelligence Report
Teva Pharmaceutical Industries - SWOT Analysis - SWOT Analysis
Takeda Pharmaceutical Company Limited - SWOT Analysis
Nastech Pharmaceutical Company Inc - SWOT Analysis
Crane Company - SWOT Analysis
Par Pharmaceutical Companies, Inc.
Sonoco Products Company - SWOT Analysis - SWOT Analysis
BioMarin Pharmaceutical Inc - SWOT Analysis
The Southern Company - SWOT Analysis
Clorox Company, The - SWOT Analysis
Tecumseh Products Company - SWOT Analysis
|
|
|
|
